Latest Listings: Africa-focused fintech Airtel Africa ($700mm) completed London's largest IPO since 2021, but broke issue on ...
City Therapeutics, a Phase 1 biotech developing RNA interference therapies for thromboembolic diseases, announced terms for ...
FireFly Robotics, which makes robotic turfgrass harvesters and autonomous golf course mowers, filed on Wednesday with the SEC ...
Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion-dollar data center developer, an emerging markets fintech, and a dental treatment company.Autoimmune biotech ...
Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, announced terms for ...
Retension Pharmaceuticals, a Phase 2b biotech developing an in-licensed treatment for hypertension, raised $45 million by ...
TRex Bio, a Phase 1 biotech developing medicines for autoimmune and inflammatory diseases, announced terms for its IPO on ...
Pop Global Acquisition, a blank check company targeting advanced software, hardware, materials and energy technologies, filed ...
Retension Pharmaceuticals, a Phase 2b biotech developing an in-licensed treatment for hypertension, announced terms for its ...
Calm Seas Acquisition, a blank check company targeting the energy and shipping industries, lowered the proposed deal size for ...
Vardis Holding, which sells proprietary non-invasive restorative treatments for early-stage cavities, filed on Friday with the SEC for an initial public offering that we estimate could raise $200 ...
While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two more on the calendar for the week ahead.RNA interference biotech City ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results